---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-22-000023"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2022-06-08T23:59:59+00:00"
generated_at: "2026-06-25T03:26:12.287196+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Charles River lowers Q2 2022 revenue and EPS outlook, cites FX and CDMO headwinds

## Summary
- Q2 reported revenue growth guidance cut from low-double-digit to high-single-digit YoY; non-GAAP EPS growth cut from mid- to high-single-digit to low- to mid-single-digit.
- Guidance reduction driven by unfavorable FX impact and manufacturing (CDMO) revenue growth below Q1 2022 level.
- DSA and RMS organic growth rates expected to accelerate from Q1; DSA trends remain in line with full-year expectations.
- Full-year 2022 organic revenue growth and non-GAAP EPS guidance maintained within prior ranges provided in May.

## SEC filing metadata
- accession: 0001100682-22-000023
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2022-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000023/0001100682-22-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068222000023/crl-20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-22-000023
- JSON: https://secwatch.observer/filing/0001100682-22-000023.json
- Plain text: https://secwatch.observer/filing/0001100682-22-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.